 | | Vol. 15.05 – 16 February, 2023 |
| |
|
|
| An intelligent biodegradable hollow manganese dioxide nanoparticle with a human umbilical cord MSC membrane coating was designed to exert efficient chemo-immunotherapy for cancer treatment.
[ACS Applied Materials & Interfaces] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers investigated the role and mechanism of human umbilical cord MSC exosomes on the repair of renal tubular epithelial cells after injury.
[Cellular & Molecular Biology Letters] |
|
|
|
| Scientists evaluated cord blood-derived endothelial progenitor cells as a potential cellular therapy for mitigation of hematologic acute radiation syndrome.
[International Journal Of Radiation Oncology Biology Physics] |
|
|
|
| The authors assessed the feasibility of umbilical cord blood-derived cell collection for autologous use in extremely preterm infants born at less than 28 weeks.
[Cytotherapy] |
|
|
|
| Investigators performed DNA methylation age analysis to measure the age of cells using post-transplant peripheral blood in 50 cases of cord blood transplantation.
[3D Printing And Additive Manufacturing] |
|
|
|
| To study the acceleration of the wound healing process, researchers bound epidermal growth factor and fibroblast growth factor 1 to heparinized human acellular amniotic membrane.
[Journal Of Biomedical Materials Research Part A] |
|
|
|
| Scientists found that matrix metalloproteinase-13 (Mmp13) was upregulated in the skin lesions of an imiquimod-induced mouse model, which was downregulated after intravenous infusion of human umbilical cord MSCs.
[Inflammation] |
|
|
|
|
| A novel therapeutic alternative involving amniotic MSC metabolite products has been developed using metabolites from stem cells containing cytokines and growth factors.
[Journal Of Biological Engineering] |
|
|
|
|
| The University of Texas MD Anderson Cancer Center and Xilis announced a strategic collaboration to deploy Xilis’ proprietary MicroOrganoSphere™ technology in support of preclinical research to accelerate the development of novel cancer therapies.
[The University of Texas MD Anderson Cancer Center] |
|
|
|
|
| April 17 – 19, 2023
Lund, Sweden |
|
|
|
|
|
| | Harvard Medical School – Boston, Massachusetts, United States |
|
|
|
| | STEMCELL Technologies, Inc. – Cambridge, England, United Kingdom |
|
|
|
| | Khalifa University – Abu Dhabi, United Arab Emirates |
|
|
|
| | Fred Hutchinson Cancer Center – Seattle, Washington, United States |
|
|
|
| | Medical College of Wisconsin – Milwaukee, Wisconsin, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
